Alexander Moeller
Overview
Explore the profile of Alexander Moeller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slob E, Kalyoncu M, Ersu R, Moeller A, Vijverberg S
ERJ Open Res
. 2025 Mar;
11(2).
PMID: 40071268
https://bit.ly/40944lv.
2.
Mallet M, Elmiger A, Glick S, Krasnova T, de Jong C, Kern B, et al.
Pediatr Pulmonol
. 2025 Feb;
60(2):e27499.
PMID: 39936634
Introduction: Prolonged or recurrent cough is a common reason for referral to pediatric pulmonologists, yet few studies have assessed its causes. We examined records of children visiting respiratory outpatient clinics...
3.
Slob E, Vijverberg S, Ruffles T, Noij L, Biermann J, Brouwer A, et al.
Allergy
. 2024 Dec;
PMID: 39723595
Background: Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially...
4.
Steinberg R, Mostacci N, Kieninger E, Frauchiger B, Casaulta C, Usemann J, et al.
Commun Med (Lond)
. 2024 Nov;
4(1):246.
PMID: 39580540
Background: Respiratory tract infections (RTIs) drive lung function decline in children with cystic fibrosis (CF). While the respiratory microbiota is clearly associated with RTI pathogenesis in infants without CF, data...
5.
Khaleva E, Brightling C, Eiwegger T, Altraja A, Begin P, Blumchen K, et al.
Eur Respir J
. 2024 Nov;
PMID: 39510551
Background: We have previously developed Core Outcome Measures sets for Severe Asthma (COMSA) by multi-stakeholder consensus. There are no patient-centred tools to quantify response to biologics for severe asthma. We...
6.
Steinberg R, Moeller A, Gisler A, Mostacci N, Hilty M, Usemann J
J Cyst Fibros
. 2024 Oct;
PMID: 39406574
Background: Triple modulator therapy elexacaftor/tezacaftor/ivacaftor (ETI) improves lung function and impacts upon the respiratory microbiome in people with Cystic fibrosis (pwCF) with advanced lung disease. However, adolescents with cystic fibrosis...
7.
Haile S, Peralta G, Adams M, Bharadwaj A, Bassler D, Moeller A, et al.
BMJ Paediatr Open
. 2024 Oct;
8(1).
PMID: 39389623
Objective: We aimed to assess health-related quality of life (HRQOL) in a cohort of very preterm born children and adolescents (aged 5-16), and to compare it with their fullterm born...
8.
Usemann J, Mozun R, Kuehni C, de Hoogh K, Flueckiger B, Singer F, et al.
Pediatr Pulmonol
. 2024 Jul;
59(12):3178-3189.
PMID: 38980223
Background: The adverse effects of high air pollution levels on childhood lung function are well-known. Limited evidence exists on the effects of moderate exposure levels during early life on childhood...
9.
Frauchiger B, Willers C, Cotting J, Kieninger E, Korten I, Casaulta C, et al.
J Cyst Fibros
. 2024 Jun;
23(5):910-917.
PMID: 38926017
Background: Non-invasive and sensitive clinical endpoints are needed to monitor onset and progression of early lung disease in children with cystic fibrosis (CF). We compared lung clearance index (LCI), FEV,...
10.
Makrinioti H, Fainardi V, Bonnelykke K, Custovic A, Cicutto L, Coleman C, et al.
Eur Respir J
. 2024 Jun;
64(3).
PMID: 38843917
Since the publication of the European Respiratory Society (ERS) task force reports on the management of preschool wheezing in 2008 and 2014, a large body of evidence has accumulated suggesting...